9 Midcap stocks with massive upside potential; up to 45%! Do you own any? – Analyst Picks
Analyst forecasts are more than just numbers; they provide a forward-looking perspective on market potential. For investors searching for the ...
Thursday, January 29, 2026
Tag: Upside
Analyst Maps Shiba Inu Roadmap With 1,800% Upside
Crypto analyst Quantum Ascend has published a weekly-chart “roadmap” for Shiba Inu (SHIB) in a new video, laying out three ...
India valuations fair, earnings key to upside over next 12 months: Mark Matthews
Indian equity markets may not deliver fireworks ahead, but they could still offer something investors value just as much — ...
Stock-picker’s market at play: Vedanta, Tata Power among 5 stocks that offer up to 22% upside – Top Picks
Tata Power is emerging as an end-to-end power solutions company with a presence across generation to distribution, to trading, and ...
Corona Remedies and Wakefit Innovations to list tomorrow; GMP suggests sharp upside for pharma play
Shares of Corona Remedies and Wakefit Innovations are set to debut on the stock exchanges on Monday, with grey market ...
Expect limited upside in near term, stick to stock-specific strategy: CA Rudramurthy BV
Despite a promising start, Indian markets have been unable to hold onto recent gains, leaving investors uncertain about the near-term ...
Elliott’s activism could drive upside as Barrick Mining hunts for new CEO
Attendees speak with representatives at the Barrick booth, at the Prospectors and Developers Association of Canada (PDAC) annual mining conference ...
Positive Breakout: These 9 stocks cross above their 200 DMAs – Upside Ahead?
In the Nifty500 pack, nine stocks' closing prices crossed above their 200 DMA (Daily Moving Averages) on December 4, 2025, ...
Inox Wind among top 9 small and midcap picks from Axis Securities with upside potential of up to 43% – Market overview
After a prolonged phase of underperformance, the Indian markets appear to be building a base for a stronger second half. ...
Should You Grab This ‘Strong Buy’ Growth Stock With 56% Upside?
BridgeBio Pharma (BBIO), a mid-cap biotech company, has investors thrilled with its commercial engine scaling following the approval of Acoramidis ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.